Pharm Company: * APOTEX INC
Category: Heart (Cardiac)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Regadenoson Overview

Regadenoson, sold under the brand name Lexiscan among others, is an A2A adenosine receptor agonist that is a coronary vasodilator that is commonly used in pharmacologic stress testing. It produces hyperemia quickly and maintains it for a duration that is useful for radionuclide myocardial perfusion imaging.[1] The selective nature of the drug makes it preferable to other stress agents such as adenosine, which are less selective and therefore cause more side-effects. Regadenoso...

Read more Regadenoson Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Regadenoson Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 0.4mg/5ml (0.08mg/ml)
  • Solution: 0.4mg/5ml (0.08mg/ml)
  • Syringe: 0.4mg/5ml
  • Vial: 0.4mg/5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Regadenoson: (1 result)

Sorted by National Drug Code
  • 51662-1448 Lexiscan(r) (Regadenoson) .08 mg/ml Intravenous Injection, Solution by Hf Acquisition Co LLC, Dba Healthfirst

Other drugs which contain Regadenoson or a similar ingredient: (1 result)